Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Naoko Kawata (Chiba, Japan), Naoko Kawata, Jiro Terada, Koichiro Tatsumi. Persistent daytime hypercapnia predicts poor prognosis in OSAS undergoing CPAP therapy. Eur Respir J 2016; 48: Suppl. 60, 3424

Member's Comments

No comment yet.

Related content which might interest you: Long-term outcome of nCPAP therapy in sleep apnoea patients Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Retrospective analysis of oxygen therapy in persistent nocturnal hypoxia despite CPAP in obstructive sleep apnoea syndrome (OSAS) Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014 Outcome with CPAP in patients with suspected sleep apnea syndrome Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Clinical implications of residual sleep apnoea after chronic CPAP therapy Source: Breathe 2011; 7: 289-290 Year: 2011 The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005 Long-term CPAP compliance in women with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Automatic CPAP performance in sleep apnea patients with associated COPD Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Residual sleepiness in patients with OSA on CPAP Source: Eur Respir J 2009; 34: 1209 Year: 2009 Predicting response to oxygen therapy in obstructive sleep apnoea patients using a 10-minute daytime test Source: Eur Respir J, 51 (1) 1701587; 10.1183/13993003.01587-2017 Year: 2018 Index for comfort of patients with obstructive sleep apnea on continuous positive airway pressure therapy Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Predicting outcome of nasal surgery in patients with obstructive sleep apnoea Source: Eur Respir J 2008; 32: 246 Year: 2008 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009